Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity

PURPOSE: The purpose of this study was to evaluate neurodevelopmental outcomes in 18-month old (corrected age) preterm infants who received an intravitreal bevacizumab (IVB) injection for the treatment of type 1 retinopathy of prematurity (ROP). METHODS: In this ten-year retrospective study, we revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arima, Mitsuru, Akiyama, Masato, Fujiwara, Kohta, Mori, Yujiro, Inoue, Hirosuke, Seki, Eiko, Nakama, Takahito, Tsukamoto, Shoko, Ochiai, Masayuki, Ohga, Shouichi, Sonoda, Koh-Hei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083318/
https://www.ncbi.nlm.nih.gov/pubmed/32196539
http://dx.doi.org/10.1371/journal.pone.0230678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083318/
https://www.ncbi.nlm.nih.gov/pubmed/32196539
http://dx.doi.org/10.1371/journal.pone.0230678

Ejemplares similares